MIM
NEO icon

Macroview Investment Management’s NeoGenomics NEO Stock Holding History

Macroview Investment Management’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-178
Closed -$2.63K – 369
2024
Q3 		$2.63K Hold
178
– – ﹤0.01% 447
2024
Q2 		$2.47K Hold
178
– – ﹤0.01% 467
2024
Q1 		$2.8K Sell
178
-364
-67% -$5.62K ﹤0.01% 487
2023
Q4 		$8.77K Sell
542
-237
-30% -$3.88K 0.01% 276
2023
Q3 		$9.58K Buy
779
+137
+21% +$2.04K 0.01% 282
2023
Q2 		$10.3K Buy
+642
New +$10.6K 0.02% 269

Other funds holding NEO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
GF
Greenhouse Funds Baltimore, Maryland $1.96B AUM 36.47% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Macroview Investment Management's NEO Position: Q4 2024 in Review

Macroview Investment Management sold out of NeoGenomics (NEO) in Q4 2024, closing a stake of 178 shares — an estimated $2.63K sold.

Macroview Investment Management first reported a position in NEO in Q2 2023 and held it in 6 quarters. The position peaked at $10.3K in Q2 2023. 253 funds tracked by Wall St. Rank hold NEO as of Q4 2024.

  • Macroview Investment Management reported no remaining NeoGenomics position as of Q4 2024 after selling out during the quarter.
  • Macroview Investment Management sold 178 NeoGenomics shares in Q4 2024, an estimated $2.63K.
  • Macroview Investment Management first reported a position in NeoGenomics in Q2 2023 and held it in 6 quarters.
  • Macroview Investment Management's NeoGenomics position peaked at $10.3K in Q2 2023.
  • 253 funds tracked by Wall St. Rank held NeoGenomics as of Q4 2024.

Based on Macroview Investment Management's 13F filing for Q4 2024, filed 31 Jan 2025.